Please login to the form below

Not currently logged in
Email:
Password:

Syneos Health announces partnership with AiCure

Will leverage proprietary intelligent software and AI-driven insights

Syneos Health

Syneos Health, an integrated biopharmaceutical solutions organisation, has partnered with AiCure for smarter clinical trials that optimise patient engagement. 

AiCure is an artificial intelligence and data analytics company, which offers proprietary intelligent software and AI-driven insights.

The partnership will see AiCure leverage Syneos’ behavioural insights-driven product development model, with the aim to capture, analyse and predict patient behaviours influencing clinical trial adherence.

“The AiCure platform aligns with our unique product developmet model that harnesses behavioural insights to unlock real world experiences,” said Alistair Macdonald, chief executive officer of Syneos Health.

“By deploying the AiCure platform to our investigative sites, we create insights-enriched patient communities to advance clinical research,” he added.

Syneos Health will have access to AiCure’s digital biomarker assessments, evaluating facial, verbal, speech and movement variables to objectively study known clinical endpoints.

The platform identifies adherence patterns and variations in site and participant engagement, providing the opportunity to modify behaviours that increase compliance for the improvement of overall trial success.

Part of this includes providing patients with a smartphone application to guide and confirm proper administration in real-time – as opposed to self-reporting measures.

“Syneos Health’s scale as a leading global CRO, and the largest contract commercial organisation, will enable valuable customer engagements and expands our reach with biopharmaceutical companies of all sizes,” said Adam Hanina, chief executive officer of AiCure

13th November 2019

From: Marketing

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Bedrock Group

Bedrock Healthcare Communications is a privately owned, award winning communications agency that creates and delivers highly effective, insight driven medical...

Latest intelligence

Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
The heavy toll of COVID-19 on cancer patients
We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...

Infographics